These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 11787477

  • 1. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects.
    O'Shaughnessy KM, Fu B, Dickerson C, Thurston D, Brown MJ.
    Clin Sci (Lond); 2000 Sep; 99(3):233-8. PubMed ID: 11787477
    [Abstract] [Full Text] [Related]

  • 2. Modifying effects of the R389G beta1-adrenoceptor polymorphism on resting heart rate and blood pressure in patients with obstructive sleep apnoea.
    Börgel J, Schulz T, Bartels NK, Epplen JT, Büchner N, Rump LC, Huesing A, Sanner BM, Mügge A.
    Clin Sci (Lond); 2006 Jan; 110(1):117-23. PubMed ID: 16122377
    [Abstract] [Full Text] [Related]

  • 3. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.
    Liu J, Liu ZQ, Tan ZR, Chen XP, Wang LS, Zhou G, Zhou HH.
    Clin Pharmacol Ther; 2003 Oct; 74(4):372-9. PubMed ID: 14534524
    [Abstract] [Full Text] [Related]

  • 4. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.
    Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF.
    Clin Pharmacol Ther; 2003 Jul; 74(1):44-52. PubMed ID: 12844134
    [Abstract] [Full Text] [Related]

  • 5. Association of CYP2D6 and ADRB1 genes with hypotensive and antichronotropic action of betaxolol in patients with arterial hypertension.
    Zateyshchikov DA, Minushkina LO, Brovkin AN, Savel'eva EG, Zateyshchikova AA, Manchaeva BB, Nikitin AG, Sidorenko BA, Nosikov VV.
    Fundam Clin Pharmacol; 2007 Aug; 21(4):437-43. PubMed ID: 17635183
    [Abstract] [Full Text] [Related]

  • 6. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
    Liu J, Liu ZQ, Yu BN, Xu FH, Mo W, Zhou G, Liu YZ, Li Q, Zhou HH.
    Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
    [Abstract] [Full Text] [Related]

  • 7. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH, Davies RA, Fourney A.
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [Abstract] [Full Text] [Related]

  • 8. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.
    Schelleman H, Klungel OH, Witteman JC, Hofman A, van Duijn CM, de Boer A, Stricker BH.
    Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011
    [Abstract] [Full Text] [Related]

  • 9. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
    Magnusson Y, Levin MC, Eggertsen R, Nyström E, Mobini R, Schaufelberger M, Andersson B.
    Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
    [Abstract] [Full Text] [Related]

  • 10. Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline.
    Snapir A, Koskenvuo J, Toikka J, Orho-Melander M, Hinkka S, Saraste M, Hartiala J, Scheinin M.
    Clin Sci (Lond); 2003 May; 104(5):509-20. PubMed ID: 12519093
    [Abstract] [Full Text] [Related]

  • 11. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J, Faülhaber HD.
    Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():77-82. PubMed ID: 15700490
    [Abstract] [Full Text] [Related]

  • 12. Job strain, job demands and adrenergic beta1-receptor-polymorphism: a possible interaction affecting blood pressure in men.
    Ohlin B, Berglund G, Nilsson PM, Melander O.
    J Hypertens; 2008 Aug 27; 26(8):1583-9. PubMed ID: 18622236
    [Abstract] [Full Text] [Related]

  • 13. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
    Zhao C, Wang YY, Xiao ZX, Wang YP, Zhang QY.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug 27; 24(4):428-31. PubMed ID: 17680535
    [Abstract] [Full Text] [Related]

  • 14. Age and responses to isometric exercise in hypertension: possible predictors of the antihypertensive effect of diuretics and beta-blockers.
    Corea L, Valori C, Bentivoglio M, Verdecchia P, Bichisao E.
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct 27; 23(10):554-9. PubMed ID: 2866164
    [Abstract] [Full Text] [Related]

  • 15. Studies of associations between the Arg389Gly polymorphism of the beta1-adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjects.
    Gjesing AP, Andersen G, Albrechtsen A, Glümer C, Borch-Johnsen K, Jørgensen T, Hansen T, Pedersen O.
    Diabet Med; 2007 Apr 27; 24(4):392-7. PubMed ID: 17335470
    [Abstract] [Full Text] [Related]

  • 16. Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers.
    Schwartz SG, Puckett BJ, Allen RC, Castillo IG, Leffler CT.
    Ophthalmology; 2005 Dec 27; 112(12):2131-6. PubMed ID: 16325708
    [Abstract] [Full Text] [Related]

  • 17. Beta-blockers do not impair the cardiovascular benefits of endurance training in hypertensives.
    Westhoff TH, Franke N, Schmidt S, Vallbracht-Israng K, Zidek W, Dimeo F, van der Giet M.
    J Hum Hypertens; 2007 Jun 27; 21(6):486-93. PubMed ID: 17330056
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of landiolol in attenuating hemodynamic responses to local epinephrine infiltration in patients undergoing vaginal total hysterectomy.
    Hirota K, Baba S, Fukushi S, Muraoka M, Matsuki A.
    J Anesth; 2005 Jun 27; 19(1):17-20. PubMed ID: 15674510
    [Abstract] [Full Text] [Related]

  • 19. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
    Biolo A, Clausell N, Santos KG, Salvaro R, Ashton-Prolla P, Borges A, Rohde LE.
    Am J Cardiol; 2008 Sep 15; 102(6):726-32. PubMed ID: 18773997
    [Abstract] [Full Text] [Related]

  • 20. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy.
    Schelleman H, Klungel OH, van Duijn CM, Witteman JC, Hofman A, de Boer A, Stricker BH.
    Ann Pharmacother; 2006 Feb 15; 40(2):212-8. PubMed ID: 16449550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.